Evidence map›Paper›PMID 32741067›Full record

ReviewMolecular oncology2021

Microenvironmental modulation of the developing tumour: an immune-stromal dialogue.

James O Jones, William M Moody, Jacqueline D Shields

Abstract readReview
In one paragraph

Review in Molecular oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James O JonesMRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
William M MoodyMRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
Jacqueline D ShieldsMRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.ORCID 0000-0003-2153-9710

Funding

Medical Research Council MC_UP_1101/2Medical Research Council MC_UU_12022/5
6 · The paper itself

Abstract

Successful establishment of a tumour relies on a cascade of interactions between cancer cells and stromal cells within an evolving microenvironment. Both immune and nonimmune cellular components are key factors in this process, and the individual players may change their role from tumour elimination to tumour promotion as the microenvironment develops. While the tumour-stroma crosstalk present in an established tumour is well-studied, aspects in the early tumour or premalignant microenvironment have received less attention. This is in part due to the challenges in studying this process in the clinic or in mouse models. Here, we review the key anti- and pro-tumour factors in the early microenvironment and discuss how understanding this process may be exploited in the clinic.

Indexed as

NeoplasmsTumor MicroenvironmentAnimalsHumansMiceStromal Cellscancer-associated fibroblastextracellular matriximmunemalignant transformationstromatumour microenvironment

Identifiers

PMID32741067
PMCPMC8486574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.